The accuracy of clinician perceptions of "usual" blood pressure control

J Gen Intern Med. 2008 Feb;23(2):180-3. doi: 10.1007/s11606-007-0464-1. Epub 2007 Nov 28.

Abstract

Background: The term "clinical inertia" is used to describe the failure to manage a chronic condition aggressively enough to bring it under control. The underlying mechanisms for clinical inertia remain poorly understood.

Objective: To describe one potential mechanism for clinical inertia, seen through the lens of clinician responses to a computerized hypertension reminder.

Design: Cohort study.

Participants: A total of 509 hypertensive patients from 2 primary care clinics in urban Veterans Health Administration (VA) Medical Centers. All patients had elevated blood pressure (BP) values that triggered a computerized reminder. Given a set of possible responses to the reminder, clinicians asserted at least once for each patient that medication adjustments were unnecessary because the BP was "usually well controlled".

Measurements: Using recent BP values from the electronic medical record, we assessed the accuracy of this assertion.

Results: In most instances (57%), recent BP values were not well controlled, with the systolic BP (56%) much more likely to be elevated than the diastolic BP (13%). Eighteen percent of recent systolic BP values were 160 mmHg or greater.

Conclusions: When clinicians asserted that the BP was "usually well controlled", objective evidence frequently suggested otherwise. This observation provides insight into one potential mechanism underlying clinical inertia.

Publication types

  • Multicenter Study
  • Research Support, U.S. Gov't, Non-P.H.S.

MeSH terms

  • Aged
  • Antihypertensive Agents / administration & dosage*
  • Clinical Audit
  • Clinical Competence*
  • Cohort Studies
  • Decision Support Systems, Clinical / statistics & numerical data*
  • Female
  • Hospitals, Veterans
  • Humans
  • Hypertension / drug therapy*
  • Male
  • Middle Aged
  • Quality of Health Care
  • Reminder Systems*
  • Treatment Failure

Substances

  • Antihypertensive Agents